Research programme: anti-inflammatory therapeutics - EA Pharma/TransThera
Latest Information Update: 01 Dec 2023
At a glance
- Originator EA Pharma; TransThera Biosciences
- Class Anti-inflammatories; Hepatoprotectants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Gastrointestinal disorders; Liver disorders